Users' perspectives on medical abortion in FinlandHONKANEN, Helena; VON HERTZEN, Helena.Contraception (Stoneham). 2002, Vol 65, Num 6, pp 419-423, issn 0010-7824Article

The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancyHONKANEN, Helena; RANTA, Sirpa; YLIKORKALA, Olavi et al.Human reproduction (Oxford. Print). 2002, Vol 17, Num 9, pp 2315-2319, issn 0268-1161Article

Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancyHONKANEN, Helena; RANTA, Sirpa; YLIKORKALA, Olavi et al.Acta obstetricia et gynecologica Scandinavica. 2005, Vol 84, Num 2, pp 134-139, issn 0001-6349, 6 p.Article

Differential kinetics of serum and cervical insulin-like growth factor-binding protein-1 during mifepristone-misoprostol-induced medical termination of early pregnancyHONKANEN, Helena; RUTANEN, Eeva-Marja; HEIKINHEIMO, Oskari et al.Molecular human reproduction. 2004, Vol 10, Num 1-2, pp 65-70, issn 1360-9947, 6 p.Article

Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivityHEIKINHEIMO, Oskari; RAIVIO, Taneli; HONKANEN, Helena et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 1, pp 323-326, issn 0021-972X, 4 p.Article

WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: EfficacyVON HERTZEN, Helena; HONKANEN, Helena; NGUYEN THI NHU NGOC et al.BJOG (Oxford. Print). 2003, Vol 110, Num 9, pp 808-818, issn 1470-0328, 11 p.Article

WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. II: Side effects and women's perceptionsHONKANEN, Helena; PIAGGIO, Gilda; NGUYEN THI NHU NGOC et al.BJOG (Oxford. Print). 2004, Vol 111, Num 7, pp 715-725, issn 1470-0328, 11 p.Article